An MSC infusion has been shown in numerous rodent studies of COPD to reduce inflammation and parenchymal damage; some reports have also implicated MSC paracrine factors, including keratinocyte growth factor (KGF), HGF, vascular endothelial growth factor, and epidermal growth factor (196–200). The gene discussed is FGF7; the disease is chronic obstructive pulmonary disease.